Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker BTAIQ
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 19,419 | $21.1K | 10b5-1 | May 20, 2026 | Form 4 ↗ 2 days later · 19,419 shares | Form 144 ↗ |
| May 20, 2026 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 6,560 | $7,109 | 10b5-1 | May 20, 2026 | Form 4 ↗ 2 days later · 6,560 shares | Form 144 ↗ |
| May 20, 2026 | Frank Yocca Officer | BTAIQ BioXcel Therapeutics, Inc. | 6,845 | $7,430 | 10b5-1 | May 20, 2026 | Form 4 ↗ 2 days later · 6,845 shares | Form 144 ↗ |
| May 20, 2026 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 6,845 | $7,426 | 10b5-1 | May 20, 2026 | Form 4 ↗ 2 days later · 6,845 shares | Form 144 ↗ |
| Dec 16, 2024 | O'Neill Vincent Officer | BTAIQ BioXcel Therapeutics, Inc. | 165 | $58.13 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 165 shares | Form 144 ↗ |
| Dec 16, 2024 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 430 | $153 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 430 shares | Form 144 ↗ |
| Dec 16, 2024 amended | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 430 | $154 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 577 shares | Form 144/A ↗ |
| Dec 16, 2024 | Frank Yocca Officer | BTAIQ BioXcel Therapeutics, Inc. | 430 | $152 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 430 shares | Form 144 ↗ |
| Dec 16, 2024 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 438 | $154 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 577 shares | Form 144 ↗ |
| Dec 16, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,315 | $453 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 3,117 shares | Form 144 ↗ |
| Dec 16, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 983 | $340 | 10b5-1 | Dec 16, 2024 | Form 4 ↗ 1 day later · 3,117 shares | Form 144 ↗ |
| Oct 3, 2024 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 6,863 | $3,776 | 10b5-1 | Oct 3, 2024 | Form 4 ↗ same day · 6,863 shares | Form 144 ↗ |
| Oct 3, 2024 | Matthew T. Wiley Officer | BTAIQ BioXcel Therapeutics, Inc. | 6,272 | $3,450 | 10b5-1 | Oct 3, 2024 | Form 4 ↗ same day · 6,272 shares | Form 144 ↗ |
| Oct 3, 2024 | O'Neill Vincent Officer | BTAIQ BioXcel Therapeutics, Inc. | 5,556 | $3,056 | 10b5-1 | Oct 3, 2024 | Form 4 ↗ same day · 5,556 shares | Form 144 ↗ |
| Oct 3, 2024 | Frank Yocca Officer | BTAIQ BioXcel Therapeutics, Inc. | 7,175 | $3,946 | 10b5-1 | Oct 3, 2024 | Form 4 ↗ same day · 7,175 shares | Form 144 ↗ |
| Oct 3, 2024 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 7,175 | $3,947 | 10b5-1 | Oct 3, 2024 | Form 4 ↗ same day · 7,175 shares | Form 144 ↗ |
| Sep 16, 2024 | Frank Yocca Officer | BTAIQ BioXcel Therapeutics, Inc. | 355 | $245 | 10b5-1 | Sep 16, 2024 | Form 4 ↗ 17 days later · 7,175 shares | Form 144 ↗ |
| Sep 16, 2024 | Matthew T. Wiley Officer | BTAIQ BioXcel Therapeutics, Inc. | 215 | $149 | 10b5-1 | Sep 16, 2024 | Form 4 ↗ 17 days later · 6,272 shares | Form 144 ↗ |
| Sep 16, 2024 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 345 | $238 | 10b5-1 | Sep 16, 2024 | Form 4 ↗ 17 days later · 6,863 shares | Form 144 ↗ |
| Sep 16, 2024 | O'Neill Vincent Officer | BTAIQ BioXcel Therapeutics, Inc. | 138 | $95.33 | 10b5-1 | Sep 16, 2024 | Form 4 ↗ 17 days later · 5,556 shares | Form 144 ↗ |
| Sep 16, 2024 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 356 | $246 | 10b5-1 | Sep 16, 2024 | Form 4 ↗ 17 days later · 7,175 shares | Form 144 ↗ |
| Sep 16, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,150 | $794 | 10b5-1 | Sep 16, 2024 | — | Form 144 ↗ |
| Sep 16, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 832 | $574 | 10b5-1 | Sep 16, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 361 | $456 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Matthew T. Wiley Officer | BTAIQ BioXcel Therapeutics, Inc. | 244 | $308 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | O'Neill Vincent Officer | BTAIQ BioXcel Therapeutics, Inc. | 155 | $199 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Frank Yocca Officer | BTAIQ BioXcel Therapeutics, Inc. | 372 | $476 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 372 | $470 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 909 | $1,173 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,225 | $1,429 | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 4, 2024 | BioXcel LLC 10% Stockholder | BTAIQ BioXcel Therapeutics, Inc. | 252,028 | $378.0K | — | Jun 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,069 | $2,810 | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,012 | $2,662 | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Matthew T. Wiley Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,008 | $2,651 | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 4,439 | $11.7K | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 829 | $2,172 | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | O'Neill Vincent Officer | BTAIQ BioXcel Therapeutics, Inc. | 165 | $432 | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Apr 4, 2024 | Frank Yocca Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,067 | $2,803 | 10b5-1 | Apr 4, 2024 | — | Form 144 ↗ |
| Sep 20, 2023 | Mueller Family 2010 Irrevocable Trust Affiliate | BTAIQ BioXcel Therapeutics, Inc. | 2,500 | $7,500 | 10b5-1 | Sep 20, 2023 | — | Form 144 ↗ |
| Sep 20, 2023 | Peter Mueller 2018 Irrevocable Family Trust affilaite | BTAIQ BioXcel Therapeutics, Inc. | 112,802 | $338.4K | 10b5-1 | Sep 20, 2023 | — | Form 144 ↗ |
| Sep 20, 2023 | Peter Mueller Officer | BTAIQ BioXcel Therapeutics, Inc. | 96,993 | $291.0K | 10b5-1 | Sep 20, 2023 | — | Form 144 ↗ |
| Jun 20, 2023 | Mueller Family 2010 Irrevocable Trust Affiliate | BTAIQ BioXcel Therapeutics, Inc. | 2,500 | $50.0K | 10b5-1 | Jun 20, 2023 | — | Form 144 ↗ |
| Jun 20, 2023 | Peter Mueller 2018 Irrevocable Family Trust Affiliate | BTAIQ BioXcel Therapeutics, Inc. | 112,802 | $2.3M | 10b5-1 | Jun 20, 2023 | — | Form 144 ↗ |
| Jun 20, 2023 | Peter Mueller Officer | BTAIQ BioXcel Therapeutics, Inc. | 96,993 | $1.9M | 10b5-1 | Jun 20, 2023 | — | Form 144 ↗ |
| Jun 15, 2023 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 60,000 | $900.0K | 10b5-1 | Jun 15, 2023 | — | Form 144 ↗ |
| May 22, 2023 | Mehta Vimal Officer | BTAIQ BioXcel Therapeutics, Inc. | 6,500 | $167.6K | 10b5-1 | May 22, 2023 | — | Form 144 ↗ |
| May 16, 2023 amended | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,785 | $48.7K | 10b5-1 | May 15, 2023 | — | Form 144/A ↗ |
| May 15, 2023 | Richard I. Steinhart Officer | BTAIQ BioXcel Therapeutics, Inc. | 5,000 | $135.7K | 10b5-1 | May 15, 2023 | — | Form 144 ↗ |
| May 15, 2023 | Javier Rodriguez Officer | BTAIQ BioXcel Therapeutics, Inc. | 1,785 | $48.7K | 10b5-1 | May 15, 2023 | — | Form 144 ↗ |
49 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances